165 related articles for article (PubMed ID: 24940827)
1. Metabolomic Profiling of Autoimmune Hepatitis: The Diagnostic Utility of Nuclear Magnetic Resonance Spectroscopy.
Wang JB; Pu SB; Sun Y; Li ZF; Niu M; Yan XZ; Zhao YL; Wang LF; Qin XM; Ma ZJ; Zhang YM; Li BS; Luo SQ; Gong M; Sun YQ; Zou ZS; Xiao XH
J Proteome Res; 2014 Aug; 13(8):3792-3801. PubMed ID: 24940827
[TBL] [Abstract][Full Text] [Related]
2. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis.
Lian JS; Liu W; Hao SR; Chen DY; Wang YY; Yang JL; Jia HY; Huang JR
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):413-21. PubMed ID: 26256087
[TBL] [Abstract][Full Text] [Related]
3. NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.
Dimou A; Zachou K; Kostara C; Azariadis K; Giannoulis G; Lyberopoulou A; Bairaktari E; Dalekos GN
Hepatology; 2024 Feb; ():. PubMed ID: 38305739
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
6. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic profiling for drug-induced liver injury with autoantibodies.
Han YZ; Ma ZT; Zhou MX; Niu M; Zhao X; Guo YM; Song XH; Lu YW; Bai ZF; Li Z; Gao H; Zhao YK; Wang JB; Xiao XH; Jing J
Int Immunopharmacol; 2022 Oct; 111():109084. PubMed ID: 35932613
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
Park Y; Cho Y; Cho EJ; Kim YJ
Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
11. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome.
Kuiper EM; Zondervan PE; van Buuren HR
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):530-4. PubMed ID: 20304098
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome.
Suzuki Y; Arase Y; Ikeda K; Saitoh S; Tsubota A; Suzuki F; Kobayashi M; Akuta N; Someya T; Miyakawa Y; Kumada H
J Gastroenterol Hepatol; 2004 Jun; 19(6):699-706. PubMed ID: 15151627
[TBL] [Abstract][Full Text] [Related]
14. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
[TBL] [Abstract][Full Text] [Related]
15. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients.
Qiu D; Wang Q; Wang H; Xie Q; Zang G; Jiang H; Tu C; Guo J; Zhang S; Wang J; Lu Y; Han Y; Shen L; Chen X; Hu X; Wang X; Chen C; Fu Q; Ma X
J Hepatol; 2011 Feb; 54(2):340-7. PubMed ID: 21056494
[TBL] [Abstract][Full Text] [Related]
16. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome.
Lee H; Stapp RT; Ormsby AH; Shah VV
Am J Clin Pathol; 2010 Mar; 133(3):430-7. PubMed ID: 20154281
[TBL] [Abstract][Full Text] [Related]
19. Anti-phosphoenolpyruvate carboxykinase 2 antibody in patients with autoimmune hepatitis.
Kanno Y; Watanabe H; Takahashi A; Abe K; Ohira H
Hepatol Res; 2014 Sep; 44(9):1019-25. PubMed ID: 24238606
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
